Literature DB >> 1992105

HTLV-I-associated leukemia/lymphoma in south Florida.

W J Harrington1, G A Miller, R R Kemper, G E Byrne, C C Whitcomb, M Rabin.   

Abstract

We report here 10 cases of adult T-cell leukemia/lymphoma (ATL) seen in South Florida between February 1988 and July 1989. All were seropositive for human T-lymphotropic virus type I (HTLV-I) and seronegative for human immunodeficiency virus type 1 (HIV-1). DNA extracted from tumor biopsies/peripheral blood lymphocytes of nine patients was shown by the polymerase chain reaction (PCR) to contain HTLV-I proviral DNA. Blot hybridization of DNA extracted from seven patients with an HTLV-I cDNA probe revealed a monoclonal pattern of proviral integration consistent with a diagnosis of ATL. Eight of the 10 patients were women. Six patients were from Haiti, three from Jamaica, and one from the Bahamas. All patients had very aggressive non-Hodgkin's lymphoma. Two patients presented with sinus and retro-orbital involvement; another had gastric lymphoma that perforated. Nine patients developed hypercalcemia. Eight patients died within 1 year of diagnosis. Two were lost to follow-up. During the course of this study, 66 new cases of non-Hodgkin's lymphoma were diagnosed at this hospital. Ten of these cases were ATL. The prevalence of HTLV-I-related lymphoma in this sample was 15%. Since tissue from all patients was not available for HTLV-I screening, however, it is possible that other cases of ATL went undetected. We conclude from this initial survey that a retroviral etiology should be considered in patients from populations known to be at risk for HTLV-I infection who present with non-Hodgkin's lymphoma.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1992105

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  1 in total

1.  Epidemiology, clinical features, and outcome of HTLV-1-related ATLL in an area of prevalence in the United States.

Authors:  Luis Malpica; Agustin Pimentel; Isildinha M Reis; Eduardo Gotuzzo; Lazaros Lekakis; Krishna Komanduri; Thomas Harrington; Glen N Barber; Juan C Ramos
Journal:  Blood Adv       Date:  2018-03-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.